Previous 10 | Next 10 |
GOLDEN, CO / ACCESSWIRE / April 21, 2020 / Vitro Diagnostics, Inc. (OTCPINK:VODG), dba Vitro Biopharma announced the filing an investigational new drug (IND) application with the FDA for clinical use of AlloRx Stem Cells ® in the treatment of COVID-19 patients in the US. Re...
Vitro Diagnostics ( OTCPK:VODG ): Q1 Net loss of $0.08M. More news on: Vitro Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
GOLDEN, CO / ACCESSWIRE / March 26, 2020 / Vitro Diagnostics, Inc. (OTCPINK:VODG), dba Vitro Biopharma, announced its 1 st quarter ended January 31 st , 2020 financial results of operations. Vitro Diagnostics Inc. ("Vitro Biopharma") is pleased to announce a record 1 st comparative quart...
GOLDEN, CO / ACCESSWIRE / March 18, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro Biopharma reports on its therapy for the Coronavirus (COVID-19) pandemic . Recent umbilical cord stem cell therapies in China to fight the Coronavirus are producing encouraging safety and effica...
GOLDEN, CO / ACCESSWIRE / February 27, 2020 / Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharma reports on a potential therapy of Coronavirus (COVID-19) infections by stem cell transplant. While this therapy is not a method to eradicate or cure Coronavirus, there is evidence to su...
GOLDEN, CO / ACCESSWIRE / January 23, 2019 / Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced its CEO letter to its shareholders including discussion of its 2019 results of operations ended October 31 st 2019 and its expansion plans for 2020. Dear Shareholders, O...
GOLDEN, CO / ACCESSWIRE / January 22, 2020 / Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma announced a private placement of Units consisting of Series A Convertible Preferred Stock ("Series A Preferred"), Class A Warrants and Class B Warrants. The Company has authorized the priva...
GOLDEN, CO / ACCESSWIRE / November 5, 2019 / Vitro Diagnostics, Inc. (OTCPK:VODG), dba Vitro Biopharma announced the appointment of Dr. In Sok Yi MD to its Scientific Advisory Board (SAB). Dr Yi is board certified in Orthopedic Surgery and Surgery of the Hand. He presently practices with...
Vitro Diagnostics ( OTCPK:VODG ): Q3 Net loss of $0.09M. More news on: Vitro Diagnostics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
GOLDEN, CO / ACCESSWIRE / September 26, 2019 / Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced its 3rd quarter ended September 24th 2019 financial results of operations. Vitro Diagnostics Inc. ("Vitro Biopharma") is pleased to announce a record 3 rd quarter in Stem C...
News, Short Squeeze, Breakout and More Instantly...
Vitro Diagnostics Inc. Company Name:
VODG Stock Symbol:
OTCMKTS Market:
GOLDEN, CO / ACCESSWIRE / October 13, 2020 / Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma announced the revocation of its SEC registration for Vitro Diagnostics, Inc while also announcing its plans for re-registration with the SEC. As noted in our prior releases, the Company...
GOLDEN, CO / ACCESSWIRE / October 1, 2020 / Vitro Diagnostics, Inc. (OTCQB:VODG), dba Vitro Biopharma, announced its 3rd quarter, ended July 31 st 2020, financial results of operations. Vitro Biopharma recorded 3rd quarter revenues of $132,066 vs $225,191 a decrease of 41% over the compara...
GOLDEN, CO / ACCESSWIRE / July 20, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro Biopharma, announced that it has engaged MaloneBailey L.L.P. (Certified Public Accounting Firm www.malonebailey.com ) as its new auditors that will be auditing the company's consolidated balance sh...